Guide to information on human medicines evaluated by European Medicines Agency: what the Agency publishes and when

EMA press briefing on EU actions to tackle shortages of GLP-1 receptor agonists, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 15:30 (CEST) to 26 June 2024, 16:15 (CEST)

Patient registries

Human medicines European public assessment report (EPAR): Atosiban SUN, atosiban, Date of authorisation: 31/07/2013, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 26, Status: Authorised

Consolidated advice pilots: information and training webinar for Applicants, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 July 2024, 15:00 (CEST) to 17 July 2024, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Neoatricon, Dopamine hydrochloride, Date of authorisation: 27/05/2024, Status: Authorised

Zypadhera

FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10

Roles and permissions matrix summary - Authority workspace - CTIS Training Programme - Module 07